Chapter 13 - Applications of genotyping and phenotyping for clinically-relevant polymorphisms of drug metabolizing enzymes and drug transporters
作者： Dorota Tomalik-Scharte , Uwe Fuhr , Andreas Lazar
DOI: 10.1016/S1567-7192(04)80014-7
关键词:
摘要:
sci-hub.se 参考文章(176)
Robert Gelber, John H. Peters, G. Ross Gordon, Anthony J. Glazko, Louis Levy, The polymorphic acetylation of dapsone in man. Clinical Pharmacology & Therapeutics. ,vol. 12, pp. 225- 238 ,(1971) , 10.1002/CPT1971122PART1225
G. A. Ellard, Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis Clinical Pharmacology & Therapeutics. ,vol. 19, pp. 610- 625 ,(1976) , 10.1002/CPT1976195PART2610
Vural Ozdemir, Werner Kalow, Bing-Kou Tang, Andrew Paterson, Scott Walker, Laszlo Endrenyi, Angela Kashuba, Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. Pharmacogenetics. ,vol. 10, pp. 373- 388 ,(2000) , 10.1097/00008571-200007000-00001
Ulrich M. Zanger, Joachim Fischer, Sebastian Raimundo, Thomas Stüven, Bernd O. Evert, Matthias Schwab, Michel Eichelbaum, Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6 Pharmacogenetics. ,vol. 11, pp. 573- 585 ,(2001) , 10.1097/00008571-200110000-00004
Monika Hitzl, Siegfried Drescher, Heiko van der Kuip, Elke Schäffeler, Joachim Fischer, Matthias Schwab, Michel Eichelbaum, Martin F. Fromm, The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics. ,vol. 11, pp. 293- 298 ,(2001) , 10.1097/00008571-200106000-00003
Claudia Marx, Christine Fischer, Thomas Lang, Christoph Behrens, Michael Gregor, Michel Eichelbaum, Ulrich Zanger, Bernd Kaskas, Matthias Schwab, Elke Schaffeler, Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism Pharmacogenetics. ,vol. 12, pp. 429- 436 ,(2002) , 10.1097/00008571-200208000-00003
R Maekura, M Ohno, K Maeda, T Fukuda, T Igarashi, I Yamaguchi, Y Yamamoto, K Komuta, M Ito, J Azuma, T Ogura, I Yamamoto, S Yokota, Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. International Journal of Tuberculosis and Lung Disease. ,vol. 4, pp. 256- 261 ,(2000)
Julia Kirchheiner, Steffen Bauer, Ingolf Meineke, Wolfgang Rohde, Verena Prang, Christian Meisel, Ivor Roots, Jurgen Brockmoller, Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers. Pharmacogenetics. ,vol. 12, pp. 101- 109 ,(2002) , 10.1097/00008571-200203000-00004
Roger Lovlie, Ann Daly, Guri Matre, Anders Molven, Vidar Steen, Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism? Pharmacogenetics. ,vol. 11, pp. 45- 55 ,(2001) , 10.1097/00008571-200102000-00006
A Jetter, U Fuhr, Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions. Die Pharmazie. ,vol. 57, pp. 595- 601 ,(2002)